-
1
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
2
-
-
0035421783
-
Profile and prevalence of aspirin resistance in patients with eardiovascular disease
-
Gum PA, Kottke-Marehant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with eardiovascular disease. Am J Cardiol 2001; 88: 230-235.
-
(2001)
Am J Cardiol
, vol.88
, pp. 230-235
-
-
Gum, P.A.1
Kottke-Marehant, K.2
Poggio, E.D.3
-
3
-
-
8344231455
-
Aspirin and Clopidogrel. Efficacy, safety, and the issue of drug resistance
-
Cattaneo M. Aspirin and Clopidogrel. Efficacy, safety, and the issue of drug resistance. Arterioseler Thromb Vase Biol 2004; 24: 1980-1987.
-
(2004)
Arterioseler Thromb Vase Biol
, vol.24
, pp. 1980-1987
-
-
Cattaneo, M.1
-
4
-
-
1342304430
-
Failure of aspirin to prevent atherothrombosis: Potential mechanisms and implications for clinical practice
-
Eikelboom JW, Hankey GJ. Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice. Am J Cardiovasc Drugs 2004; 4: 57-67.
-
(2004)
Am J Cardiovasc Drugs
, vol.4
, pp. 57-67
-
-
Eikelboom, J.W.1
Hankey, G.J.2
-
5
-
-
0037454168
-
A prospective, blinded determination of the natural his- tory of aspirin resistance among stable patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural his- tory of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961-965.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 961-965
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Welsh, P.A.3
-
6
-
-
0037454169
-
Aspirin resistance: A new independent predictor of vascular events?
-
Eikelboom JW, Hankey GJ. Aspirin resistance: a new independent predictor of vascular events? J Am Coll Cardiol 2003; 41: 966-968.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 966-968
-
-
Eikelboom, J.W.1
Hankey, G.J.2
-
8
-
-
42949165089
-
The role of aspirin in cardiovascular prevention: Implications of aspirin resistance
-
Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008; 51: 1829-1843.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1829-1843
-
-
Gasparyan, A.Y.1
Watson, T.2
Lip, G.Y.3
-
10
-
-
39749155679
-
Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests
-
Harrison P, Segal H, Silver L, et al. Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 2008; 19: 119-124.
-
(2008)
Platelets
, vol.19
, pp. 119-124
-
-
Harrison, P.1
Segal, H.2
Silver, L.3
-
11
-
-
0033960903
-
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
-
Homoncik M, Jilma B, HergovichN, et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000;83:316-321.
-
(2000)
Thromb Haemost
, vol.83
, pp. 316-321
-
-
Homoncik, M.1
Jilma, B.2
HergovichN3
-
12
-
-
2942519743
-
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)
-
Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363: 1925-1933.
-
(2004)
Lancet
, vol.363
, pp. 1925-1933
-
-
Rothwell, P.M.1
Coull, A.J.2
Giles, M.F.3
-
13
-
-
27844562639
-
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)
-
Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366: 1773-1783.
-
(2005)
Lancet
, vol.366
, pp. 1773-1783
-
-
Rothwell, P.M.1
Coull, A.J.2
Silver, L.E.3
-
14
-
-
4344650039
-
Direct assessment of completeness of ascertainment in a stroke incidence study
-
Coull AJ, Silver LE, Bull LM, et al. Direct assessment of completeness of ascertainment in a stroke incidence study. Stroke 2004; 35: 2041-2045.
-
(2004)
Stroke
, vol.35
, pp. 2041-2045
-
-
Coull, A.J.1
Silver, L.E.2
Bull, L.M.3
-
15
-
-
18244392669
-
Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry
-
Harrison P, Segal H, Blasbery K, et al. Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 2005; 36: 1001-1005.
-
(2005)
Stroke
, vol.36
, pp. 1001-1005
-
-
Harrison, P.1
Segal, H.2
Blasbery, K.3
-
16
-
-
0032919477
-
Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis
-
Harrison P, Robinson MS, Mackie IJ, et al. Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis 1999; 10: 25-31.
-
(1999)
Blood Coagul Fibrinolysis
, vol.10
, pp. 25-31
-
-
Harrison, P.1
Robinson, M.S.2
Mackie, I.J.3
-
17
-
-
0034867946
-
Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction
-
Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-163.
-
(2001)
J Lab Clin Med
, vol.138
, pp. 152-163
-
-
Jilma, B.1
-
18
-
-
38349126676
-
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review
-
Crescente M, Di CA, Lacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008;99: 14-26.
-
(2008)
Thromb Haemost
, vol.99
, pp. 14-26
-
-
Crescente, M.1
Di, C.A.2
Lacoviello, L.3
-
19
-
-
0035869295
-
Allele-dependent transcriptional regulation of the human integrin alpha 2 gene
-
Jacquelin B, Tarantino MD, Kritzik M, et al. Allele-dependent transcriptional regulation of the human integrin alpha 2 gene. Blood 2001; 97: 1721-1726.
-
(2001)
Blood
, vol.97
, pp. 1721-1726
-
-
Jacquelin, B.1
Tarantino, M.D.2
Kritzik, M.3
-
20
-
-
0032173427
-
-
Kritzik M. Savage B, Nugent DJ, et al. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles which are associated with differences in platelet alpha 2 beta 1. Blood 1998; 92: 2382-2388.
-
Kritzik M. Savage B, Nugent DJ, et al. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles which are associated with differences in platelet alpha 2 beta 1. Blood 1998; 92: 2382-2388.
-
-
-
-
21
-
-
0028173806
-
Localization of the Br polymorphism on a 144 bp Exon of the GPIa gene and its application in platelet DNA typing
-
Kalb R, Santoso S, UnkelbachK. et al. Localization of the Br polymorphism on a 144 bp Exon of the GPIa gene and its application in platelet DNA typing. Thromb Haemost 1994; 71: 651-654.
-
(1994)
Thromb Haemost
, vol.71
, pp. 651-654
-
-
Kalb, R.1
Santoso, S.2
UnkelbachK3
-
22
-
-
25144435979
-
Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: Gene frequencies and linkage disequilibrium in a population diversity panel
-
Di Paola J, Jugessur A, Goldman T, et al. Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost 2005; 3: 1511-1521.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1511-1521
-
-
Di Paola, J.1
Jugessur, A.2
Goldman, T.3
-
23
-
-
0033937685
-
Genetic variants of platelet glycoprotein receptors and risk of stroke in young women
-
Reiner AP. Kumar FN, Schwartz SM, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000; 31: 1628-1633.
-
(2000)
Stroke
, vol.31
, pp. 1628-1633
-
-
Reiner, A.P.1
Kumar, F.N.2
Schwartz, S.M.3
-
24
-
-
0024588794
-
-
Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PLA1 and PLA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781.
-
Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PLA1 and PLA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781.
-
-
-
-
25
-
-
0033168684
-
Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib- IX-V complex
-
Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M. et al. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib- IX-V complex. Blood 1999; 94: 186-191.
-
(1999)
Blood
, vol.94
, pp. 186-191
-
-
Afshar-Kharghan, V.1
Li, C.Q.2
Khoshnevis-Asl, M.3
-
26
-
-
0029897135
-
Systematic screening for genetic polymorphism in human platelet glycoprotein Ib alpha
-
Kaski S, Kekomaki R, Partanen J. Systematic screening for genetic polymorphism in human platelet glycoprotein Ib alpha. Immunogenetics 1996; 44: 170-176.
-
(1996)
Immunogenetics
, vol.44
, pp. 170-176
-
-
Kaski, S.1
Kekomaki, R.2
Partanen, J.3
-
27
-
-
0026610362
-
145 amino acid polymorphism, which is associated with the HBA-2 (Ko) alloantigens
-
145 amino acid polymorphism, which is associated with the HBA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-384.
-
(1992)
J Clin Invest
, vol.89
, pp. 381-384
-
-
Kuijpers, R.W.A.M.1
Faber, N.M.2
Cuypers, H.T.M.3
-
28
-
-
0026720406
-
Genetic and structural characterization of an amino acid dimorphism in glycoprotein Iba involved in platelet transfusion refractoriness
-
Murata M, Furihata K, Ishida F, et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Iba involved in platelet transfusion refractoriness. Blood 1992; 79: 3086-3090.
-
(1992)
Blood
, vol.79
, pp. 3086-3090
-
-
Murata, M.1
Furihata, K.2
Ishida, F.3
-
29
-
-
4944264978
-
An association of candidate gene haplotypes and bleeding severity in Von Willebrand Disease (VWD) type 1 pedigrees
-
Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in Von Willebrand Disease (VWD) type 1 pedigrees. Blood 2004; 104: 2359-2367.
-
(2004)
Blood
, vol.104
, pp. 2359-2367
-
-
Kunicki, T.J.1
Federici, A.B.2
Salomon, D.R.3
-
30
-
-
0038819123
-
The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression
-
Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101:4372-4379.
-
(2003)
Blood
, vol.101
, pp. 4372-4379
-
-
Joutsi-Korhonen, L.1
Smethurst, P.A.2
Rankin, A.3
-
32
-
-
28444484957
-
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
-
Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005; 3: 2340-2345.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2340-2345
-
-
Maree, A.O.1
Curtin, R.J.2
Chubb, A.3
-
33
-
-
0346433909
-
In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of plasma von Willebrand factor
-
Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004; 124: 80-85.
-
(2004)
Br J Haematol
, vol.124
, pp. 80-85
-
-
Chakroun, T.1
Gerotziafas, G.2
Robert, F.3
-
34
-
-
39549117350
-
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A systematic review and meta-analysis
-
Reny JL, de MP, Dauzat M, et al. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 444-450.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 444-450
-
-
Reny1
JL, D.M.2
Dauzat, M.3
-
35
-
-
38949119325
-
Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Blister SJ, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008; 336: 195-198.
-
(2008)
BMJ
, vol.336
, pp. 195-198
-
-
Krasopoulos, G.1
Blister, S.J.2
Beattie, W.S.3
-
36
-
-
34447503098
-
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: A systematic review and meta-analysis
-
Snoep JD, Hovens MM, Eikenboom JC, et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593-1599.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1593-1599
-
-
Snoep, J.D.1
Hovens, M.M.2
Eikenboom, J.C.3
-
37
-
-
44949172436
-
PFA-100 closure time to predict cardiovascular events in aspirintreated cardiovascular patients: A meta-analysis of 19 studies comprising 3,003 patients
-
Crescente M, Di CA, Lacoviello L, et al. PFA-100 closure time to predict cardiovascular events in aspirintreated cardiovascular patients: A meta-analysis of 19 studies comprising 3,003 patients. Thromb Haemost 2008; 99: 1129-1131.
-
(2008)
Thromb Haemost
, vol.99
, pp. 1129-1131
-
-
Crescente, M.1
Di, C.A.2
Lacoviello, L.3
-
38
-
-
33344478392
-
Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls
-
Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367:651-658.
-
(2006)
Lancet
, vol.367
, pp. 651-658
-
-
Ye, Z.1
Liu, E.H.2
Higgins, J.P.3
-
39
-
-
0038267247
-
The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis
-
Kunicki TJ, Nugent DJ. The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sang 2002; 83: 85-90.
-
(2002)
Vox Sang
, vol.83
, pp. 85-90
-
-
Kunicki, T.J.1
Nugent, D.J.2
-
40
-
-
0034073762
-
The P1(A2) polymorphism of integrin beta(3) enhances outdie-in signaling and adhesive functions
-
VijayanKV, Goldschmidt-Clermont PJ, Roos C, et al. The P1(A2) polymorphism of integrin beta(3) enhances outdie-in signaling and adhesive functions, J Clin Invest 2000; 105:793-802.
-
(2000)
J Clin Invest
, vol.105
, pp. 793-802
-
-
VijayanKV1
Goldschmidt-Clermont, P.J.2
Roos, C.3
-
41
-
-
18244414272
-
Platelet GP IIIa PI(A) polymorphisms display different sensitivities to agonists
-
Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa PI(A) polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013-1018.
-
(2000)
Circulation
, vol.101
, pp. 1013-1018
-
-
Michelson, A.D.1
Furman, M.I.2
Goldschmidt-Clermont, P.3
-
42
-
-
0033761053
-
Relationship between bleeding time, aspirin and the P1A1/A2 polymorphism of platelet glycoprotein IIIa
-
Szczeklik A, Lindas A, Sanak M, et al. Relationship between bleeding time, aspirin and the P1A1/A2 polymorphism of platelet glycoprotein IIIa, Br J Haematol 2000; 110:965-967.
-
(2000)
Br J Haematol
, vol.110
, pp. 965-967
-
-
Szczeklik, A.1
Lindas, A.2
Sanak, M.3
-
43
-
-
0035852892
-
Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation
-
Szezeklik A, Sanak M, Undas A. Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation. Circulation 2001; 103: E33-E34.
-
(2001)
Circulation
, vol.103
-
-
Szezeklik, A.1
Sanak, M.2
Undas, A.3
-
44
-
-
0042735242
-
Resistance in vitro to low-dose aspirin is associated with platelet P1A1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms
-
Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet P1A1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003; 42: 1115-1119.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1115-1119
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
45
-
-
31644438586
-
Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination
-
Cooke GE, Liu-StrattonY, Ferketich AK, et al. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination. J Am Coll Cardiol 2006; 47: 541-546.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 541-546
-
-
Cooke, G.E.1
StrattonY, L.2
Ferketich, A.K.3
-
46
-
-
0032565146
-
PIA2 polymorphism and efficacy of aspirin
-
Cooke GE, Bray PF, Hamlington JD, et al. PIA2 polymorphism and efficacy of aspirin. Lancet 1998; 351: 1253-1253.
-
(1998)
Lancet
, vol.351
, pp. 1253-1253
-
-
Cooke, G.E.1
Bray, P.F.2
Hamlington, J.D.3
-
47
-
-
33845490833
-
Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and elopidogrel
-
Lev EI, Patel RT, Gufhikonda S, et al. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and elopidogrel. Thromb Res 2007; 119: 355-360.
-
(2007)
Thromb Res
, vol.119
, pp. 355-360
-
-
Lev, E.I.1
Patel, R.T.2
Gufhikonda, S.3
-
48
-
-
33751531567
-
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease
-
Bernardo E, Angiolillo DJ, Ramirez C, et al. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease. Platelets 2006; 17: 586-590.
-
(2006)
Platelets
, vol.17
, pp. 586-590
-
-
Bernardo, E.1
Angiolillo, D.J.2
Ramirez, C.3
-
50
-
-
12844269195
-
Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous response or aspirin failure?
-
Gonzalez-Conejero R, Rivera J, Corral J, et al. Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? Stroke 2005; 36: 276-280.
-
(2005)
Stroke
, vol.36
, pp. 276-280
-
-
Gonzalez-Conejero, R.1
Rivera, J.2
Corral, J.3
-
51
-
-
33645546989
-
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients
-
Lepantalo A, Mikkelsson J, Resendiz JC, et al. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thromb Haemost 2006; 95: 253-259.
-
(2006)
Thromb Haemost
, vol.95
, pp. 253-259
-
-
Lepantalo, A.1
Mikkelsson, J.2
Resendiz, J.C.3
-
52
-
-
38649098154
-
Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms
-
Takahashi S, Ushida M, Komine R, et al. Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms. Thromb Res 2008; 121: 509-517.
-
(2008)
Thromb Res
, vol.121
, pp. 509-517
-
-
Takahashi, S.1
Ushida, M.2
Komine, R.3
-
53
-
-
0037101578
-
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
-
Macchi L, Christiaens L, Brabant S, et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res 2002; 107: 45-49.
-
(2002)
Thromb Res
, vol.107
, pp. 45-49
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
54
-
-
47249143688
-
Pharmacogenetics of aspirin resistance: A comprehensive systematic review
-
Goodman T, Ferro A, Sharma E Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol 2008; 66: 222-232.
-
(2008)
Br J Clin Pharmacol
, vol.66
, pp. 222-232
-
-
Goodman, T.1
Ferro, A.2
Sharma, E.3
|